[1]赵莹,吴伟慎,何海艳,等.天津市新型冠状病毒肺炎确诊病例治愈出院后核酸阳转情况分析[J].第三军医大学学报,2020,42(09):879-882.
 ZHAO Ying,WU Weishen,HE Haiyan,et al.Analysis of re-positive nucleic acid conversion in patients recovered from COVID-19 in Tianjin[J].J Third Mil Med Univ,2020,42(09):879-882.
点击复制

天津市新型冠状病毒肺炎确诊病例治愈出院后核酸阳转情况分析(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第09期
页码:
879-882
栏目:
特别报道
出版日期:
2020-05-15

文章信息/Info

Title:
Analysis of re-positive nucleic acid conversion in patients recovered from COVID-19 in Tianjin
作者:
赵莹吴伟慎何海艳魏兆飞张国平
天津市疾病预防控制中心新型冠状病毒肺炎疫情处置组
Author(s):
ZHAO Ying WU Weishen HE Haiyan WEI Zhaofei ZHANG Guoping

Epidemiology Working Group for COVID-19, Tianjin Center for Disease Control and Prevention, Tianjin, 300011, China

关键词:
新型冠状病毒肺炎新型冠状病毒核酸复阳天津流行病学
Keywords:
corona virus disease 2019 SARS-CoV-2 nucleic acid re-positive Tianjin epidemiology  
分类号:
R373.1; R446.5; R563.1
文献标志码:
A
摘要:

目的对天津市确诊新型冠状病毒肺炎病例治愈出院后病毒核酸重新转阳病例进行分析。方法 对中国疾病预防控制信息系统报告的天津市确诊新型冠状病毒肺炎109例出院患者中,8例核酸重新转阳的病例进行监测,包括病例流行病学史、发病时间、临床表现等调查并定期病毒核酸检测,分析流行病学特征。结果 截至2020年3月7日,天津市确诊新型冠状病毒肺炎病例康复出院后病毒核酸转阳率为7.34%(8/109)。病毒核酸阳性的8例病程中位时间为20.5(14.0~28.0)d,与病毒核酸阴性病例相比差异无统计学意义。8份病毒核酸阳性样本中粪便标本或肛拭子占62.50%(5/8),咽拭子占37.50%(3/8)。8例病例均有明确的流行病学史,核酸重新转阳时12.5%(1/8)出现临床症状,但均未造成续发传播。结论 天津市新型冠状病毒肺炎病例出院后存在病毒核酸重新转阳的现象,未造成续发传播。建议治愈、隔离观察前增加粪便核酸检测指标,病例出院后定期进行核酸检测。

Abstract:

Objective To analyze the re-positive nucleic acid cases in patients recovered from coronavirus disease 2019 (COVID-19) in Tianjin, and to provide suggestions on making prevention and control strategies. MethodsAmong the 109 confirmed COVID-19 patients in Tianjin who were reported by the China Information System for Disease Control and Prevention, 8 patients re-positive for nucleic acid test after discharge were enrolled in this study. Their conditions after discharge were monitored by our group, including epidemiology, onset time, symptoms, and results of regular viral nucleic acid test. The epidemiological characteristics were analyzed. ResultsAs of March 7, 2020, the positive rate of re-positive nucleic acid conversion in patients recovered from COVID-19 was 7.34% (8/109). The median days of disease was 20.5 (14.0~28.0) d in 8 re-positive cases, which was not statistically different from those with negative results after discharge. Among the viral nucleic acid-positive samples, fecal specimens or anal swabs accounted for 62.50% (5/8), and throat swabs for 37.50% (3/8).  All 8 cases had identified epidemiological history. When the nucleic acid re-positive, 12.50% of them (1/8) had clinical symptoms, but they did not cause any secondary transmission.ConclusionRe-positiveness for nucleic acid test are found in the COVID-19 patients after discharge in Tianjin, but no one causes further transmission till now. It is recommended to add standards for fecal nucleic acid test during discharge and quarantine, regularly nucleic acid detection after the patient is discharged from the hospital.

参考文献/References:

[1]中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J]. 中华流行病学杂志, 2020, 41(2):139-144. DOI:10.3760/cma.j.issn.0254-6450.2020.02.002.
Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of Chinese Preventive Medicine Association. An update on the epidemiological characteristics of an outbreak of novel coronavirus pneumonia(COVID-19) [J]. Chin J Epidemiol, 2020,41(2): 139-144.DOI:10.3760/cma.j.issn.0254-6450.2020.02.002.
[2]广东省人民政府新闻办公室. 广东省政府新闻办疫情防控第二十五场新闻发布会[EB/OL]. [2020-02-25]. http://gdio.southcn.com/g/2020-02/19/content_190375424.htm.
Information Office of the People’s Government of Guangdong Province. The 25th Press Conference of the Guangdong Provincial Government’s Information Office on Epidemic Prevention and Control[EB/OL]. [2020-02-25].http://gdio.southcn.com/g/2020-02/19/content_190375424.htm.
[3]LAN L, XU D, YE G M, et al. Positive RT-PCR test results in patients recovered from COVID-19[J]. JAMA, 2020. DOI:10.1001/jama.2020.2783.
[4]邹静波,周杨,乔洁, 等. 关于重庆地区在治疗后的“新冠”病人粪便中发现2019新型冠状病毒核酸阳性的病例报告[J/OL].病毒学报. https://doi.org/10.13242/j.cnki.bingduxuebao.003653.
ZOU J B, ZHOU Y, QIAO J, et al. Case report on the discovery of 2019 new coronavirus-positive nucleic acid-positive cases in the stools of COVID-19 patients after treatment in Chongqing[J/OL]. Chin J Virol.https://doi.org/10.13242/j.cnki.bingduxuebao.003653.
[5]LING Y, XU S B, LIN Y X, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients[J]. Chin Med J, 2020.DOI:10.1097/CM9.0000000000000774.
[6]国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. [2020-03-03].http://www.gov.cn/zhengce/zhengceku/2020-03/04/5486705/files/ae61004f930d47598711a0d4cbf 874a9.pdf.
General Office of National Health Commission,  Office of National Administration of Traditional Chinese Medicine. Diagnostic and treatment protocol for Novel Coronavirus Pneumonia (Trial Seventh Edition)[EB/OL].[2020-03-03]. http://www.gov.cn/zhengce/zhengceku/2020-03/04/5486705/files/ae61004f930d47598711a0d4cbf874a9.pdf.
[7]国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎防控方案(第五版)[EB/OL]. [2020-02-21].http://www.gov.cn/zhengce/zhengceku/2020-02/22/5482010/files/310fd7316a89431d977cc8f2dbd2b3e0.pdf.
General Office of National Health Commission,  Office of National Administration of Traditional Chinese Medicine. Prevention and control protocol for Novel coronavirus pneumonia (Fifth Edition)[EB/OL].[2020-02-21].http://www.gov.cn/zhengce/zhengceku/2020-02/22/5482010/files/310fd7316 a89431d977cc8f2dbd2 b3e0.pdf.
[8]国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎防控方案(第四版)[EB/OL]. [2020-02-06].http://www.gov.cn/zhengce/zhengceku/2020-02/07/5475813/files/9a774a4defee44daa05894138bd0509a.pdf.
General Office of National Health Committee, Office of State Administration of traditional Chinese Medicine. Novel coronavirus pneumonia prevention and control program (Fourth Edition) [EB/OL]. [2020-02-06].http://www.gov.cn/zhengce/zhengceku/2020-02/07/5475813/files/9a774a4defe e44daa05894138bd0509a.pdf.
[9]天津市疾病预防控制中心. 天津市新冠肺炎确诊病例出院后随访与检测方案[Z]. [2020-02-28].
Tianjin Centers for Disease Control and Prevention. Follow-up and detection plan for new cases of newly diagnosed pneumonia in Tianjin[Z]. [2020-02-28].
[10]WHO. Coronavirus disease (COVID-2019) situation reports-46[EB/OL].[2020-03-06].https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-sitrep-46- covid-19.pdf?sfvrsn=96b04adf_2.
[11]中国疾病预防控制中心办公室. 中国疾病预防控制中心关于新型冠状病毒无症状感染流行情况及其传染性的初步分析报告[Z]. [2020-03-01].
Office of China Center for Disease Control and Prevention. Preliminary analysis report on asymptomatic infections of new coronaviruses and their infectivity in China[Z].[2020-03-01].
[12]ZHOU J, LI C, ZHAO G Y, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus[J]. Sci Adv, 2017, 3(11): eaao4966. DOI:10.1126/sciadv.aao4966.
[13]WANG X W, LI J S, GUO T K, et al. Excretion and detection of SARS coronavirus and its nucleic acid from digestive system[J]. World J Gastroenterol, 2005, 11(28): 4390-4395. DOI:10.3748/wjg.v11.i28.4390.
[14]古佳传. 急性呼吸道感染分泌物病毒病原检测标本选择[J]. 中国实用医药, 2011, 6(12): 124-125. DOI:10.3969/j.issn.1673-7555.2011.12.093.
GU J C. Selection of specimens for detection of pathogens of acute respiratory infection secretion virus[J]. China Pract Med,2011,6(12):124-125.DOI:10.3969/j.issn.1673-7555.2011.12.093.
[15]国务院联防联控机制新闻发布会[EB/OL]. [2020-02-28]. http://www.gov.cn/xinwen/gwylflk jz36/index.htm.
Press conference of joint defense and control mechanism of the State Council[EB/OL]. [2020-02-28]. http://www.gov.cn/xinwen/gwylflk jz36/index.htm.
[16]YAO X H, HE Z C, LI T Y, et al. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient[J]. Cell Res, 2020. DOI:10.1038/s41422-020-0318-5.

更新日期/Last Update: 2020-05-06